Published in Am J Respir Crit Care Med on July 01, 1998
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax (2005) 2.39
Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol (2007) 2.25
Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa. Infect Immun (2012) 0.99
Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax (2000) 0.98
Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLoS One (2014) 0.96
Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J Breath Res (2008) 0.95
Anr and its activation by PlcH activity in Pseudomonas aeruginosa host colonization and virulence. J Bacteriol (2013) 0.91
Concentration of the antibacterial precursor thiocyanate in cystic fibrosis airway secretions. Free Radic Biol Med (2011) 0.86
Effect of nebulised L- and D-arginine on exhaled nitric oxide in steroid naive asthma. Thorax (2001) 0.84
Oral streptococci and nitrite-mediated interference of Pseudomonas aeruginosa. Infect Immun (2014) 0.83
Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis. Thorax (2006) 0.78
Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway. J Cyst Fibros (2010) 0.78
The OpdQ porin of Pseudomonas aeruginosa is regulated by environmental signals associated with cystic fibrosis including nitrate-induced regulation involving the NarXL two-component system. Microbiologyopen (2015) 0.77
Global regulator Anr represses PlcH phospholipase activity in Pseudomonas aeruginosa when oxygen is limiting. Microbiology (2014) 0.76
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs. J Leukoc Biol (2016) 0.75
Breath tests in respiratory and critical care medicine: from research to practice in current perspectives. Biomed Res Int (2013) 0.75
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med (1999) 0.75
The atypical response regulator AtvR is a new player in Pseudomonas aeruginosa response to hypoxia and virulence. Infect Immun (2017) 0.75
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med (1996) 4.25
Cancer in the offspring of radiation workers: a record linkage study. BMJ (1997) 3.13
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med (1997) 2.55
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med (1999) 2.44
Effects of mental stress on myocardial ischemia during daily life. JAMA (1997) 2.30
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet (1997) 2.30
Mental stress--induced myocardial ischemia and cardiac events. JAMA (1996) 2.20
Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax (1997) 2.19
Statistics: all together now, one step at a time. Exp Physiol (2011) 1.76
Phosphorylation of subunit proteins of intermediate filaments from chicken muscle and nonmuscle cells. Proc Natl Acad Sci U S A (1979) 1.72
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer. Ann Oncol (2010) 1.63
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol (1997) 1.62
Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol (1996) 1.61
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59
Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis (1988) 1.57
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J (2001) 1.55
Inotropic therapy for heart failure: an evidence-based approach. Am Heart J (2001) 1.55
Etiology of large pericardial effusions. Am J Med (1993) 1.53
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol (2001) 1.51
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J (2007) 1.45
Phosphorylation of intermediate filament proteins by cAMP-dependent protein kinases. Cell (1981) 1.44
Does pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet (1982) 1.43
Diffuse panbronchiolitis: East meets West. Eur Respir J (2007) 1.40
The remarkable structural and functional organization of the eukaryotic pyruvate dehydrogenase complexes. Proc Natl Acad Sci U S A (2001) 1.40
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2001) 1.38
Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation (1999) 1.36
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology (1982) 1.31
Statistics: all together now, one step at a time. J Physiol (2011) 1.31
Systematic review of endoscopic treatments for gastro-oesophageal reflux disease. Br J Surg (2009) 1.29
Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun (2006) 1.26
Desmin- and vimentin-containing filaments and their role inthe assembly of the Z disk in muscle cells. Cold Spring Harb Symp Quant Biol (1982) 1.25
Statistics: all together now, one step at a time. Br J Nutr (2011) 1.23
Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc Natl Acad Sci U S A (2001) 1.22
DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol (2000) 1.21
High prevalence of familial sarcoidosis in an Irish population. Thorax (1984) 1.20
Progesterone induces a rapid increase in [Ca2+]in of Xenopus laevis oocytes. Proc Natl Acad Sci U S A (1980) 1.18
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol (1998) 1.18
Kinetic analysis of amino acid pools and protein synthesis in amphibian oocytes and embryos. Dev Biol (1978) 1.16
Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination. J Biol Chem (2000) 1.15
Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax (1980) 1.14
Recovery from severe paraquat poisoning following forced diuresis and immunosuppressive therapy. J Ir Med Assoc (1971) 1.12
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol (1997) 1.11
Calcium, potassium, and sodium exchange by full-grown and maturing Xenopus laevis oocytes. Dev Biol (1977) 1.10
Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax (1988) 1.10
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
Elastin and collagen remodeling in emphysema. A scanning electron microscopy study. Am J Pathol (1996) 1.10
A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusion. A follow-up report. Ann Surg (1993) 1.09
Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am J Respir Cell Mol Biol (1999) 1.08
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res (2001) 1.08
alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis (1993) 1.08
Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med (1999) 1.07
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J (2002) 1.07
Meconium ileus equivalent in older patients with cystic fibrosis. Br Med J (Clin Res Ed) (1983) 1.07
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail (2003) 1.05
Depression in patients with coronary artery disease. Depression (1996) 1.05
Lancefield group C streptococcal endocarditis. Thorax (1974) 1.05
A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest (2000) 1.04
Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. Chest (1992) 1.04
Isolation and characterization of four inhibitors from wheat flour which display differential inhibition specificities for human salivary and human pancreatic alpha-amylases. Biochim Biophys Acta (1981) 1.04
Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res (1990) 1.03
Granulomatous hepatitis of obscure aetiology. Diagnostic contribution of Kveim testing and anti-tuberculous therapy. Q J Med (1971) 1.02
The benefit of implementing a heart failure disease management program. Arch Intern Med (2001) 1.01
Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax (1989) 1.01
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation (1993) 0.99
Specific recognition of altered polypeptides by widely distributed methyltransferases. Biochem Biophys Res Commun (1985) 0.98
Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol (1997) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Methylation of chicken fibroblast heat shock proteins at lysyl and arginyl residues. J Biol Chem (1982) 0.96
L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2009) 0.96
Methylation of erythrocyte membrane proteins at extracellular and intracellular D-aspartyl sites in vitro. Saturation of intracellular sites in vivo. J Biol Chem (1983) 0.96
Fatal recurrence of neuroleptic malignant syndrome. Br J Psychiatry (1988) 0.95
Altered gastrointestinal immune response in sarcoidosis. Gut (1988) 0.95
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy. Eur J Heart Fail (1999) 0.94
Biomechanical variables associated with Achilles tendinopathy in runners. Br J Sports Med (2008) 0.94
Cardiac troponins in congestive heart failure. Am Heart J (1999) 0.94
Chronic hypercapnia inhibits hypoxic pulmonary vascular remodeling. Am J Physiol Heart Circ Physiol (2000) 0.93
Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J (1998) 0.93
Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med (1998) 0.93
The changing profile of tuberculosis in a general teaching hospital--a five-year review of 121 cases. Ir Med J (1982) 0.93
Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge. Int J Cardiol (2000) 0.93
Chronic airway infection leads to angiogenesis in the pulmonary circulation. J Appl Physiol (1985) (2001) 0.92
Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease. Arch Dis Child Fetal Neonatal Ed (2001) 0.92
Carbonic anhydrase activity in mammalian skeletal and cardiac muscle. Biochem J (1977) 0.92
Comparative study of chromium biosorption by red, green and brown seaweed biomass. Chemosphere (2007) 0.92
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol (2000) 0.92
Gentle exercise with a previously inactive muscle group hastens the decline of blood lactate concentration after strenuous exercise. Eur J Appl Physiol Occup Physiol (1991) 0.91
Interleukin-8 and leukotriene-B(4), but not formylmethionyl leucylphenylalanine, stimulate CD18-independent migration of neutrophils across human pulmonary endothelial cells in vitro. Am J Respir Cell Mol Biol (2000) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Synthesis of cobalamin-biotin conjugates that vary in the position of cobalamin coupling. Evaluation of cobalamin derivative binding to transcobalamin II. Bioconjug Chem (1997) 0.90
Kinetic and electrophoretic analysis of transmethylation reactions in intact Xenopus laevis oocytes. J Biol Chem (1987) 0.90
Mycoplasmal pericarditis: evidence of invasive disease. Clin Infect Dis (1993) 0.90
Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes. J Card Fail (2001) 0.90
Ultrastructure of lung elastin and collagen in mouse models of spontaneous emphysema. Matrix Biol (1999) 0.90
The effect of major depression on functional status in patients with coronary artery disease. J Am Geriatr Soc (1999) 0.90
An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis. Eur J Hum Genet (2001) 0.90